Youngevity International, Inc. (YGYI)

Other OTC - Other OTC Delayed Price. Currency in USD

Visitors trend2W10W9M

0.0021

0.0000

(0.00%)

As of 09:30AM EDT. Market open.

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0021
Open	0.0021
Bid	0.0000 x 1200
Ask	0.0000 x 1200
Day's Range	0.0021 - 0.0021
52 Week Range	0.0010 - 0.1000
Volume	1,007
Avg. Volume	414

Market Cap	71,493
Beta (5Y Monthly)	3.07
PE Ratio (TTM)	N/A
EPS (TTM)	-1.6100
Earnings Date	Sep 22, 2023 - Sep 24, 2023
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for YGYI

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Youngevity International, Inc.
USNA: Lowering target price to $61.00USANA HEALTH SCIENCES INC has an Investment Rating of HOLD; a target price of $61.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
Rating
Fair Value
Economic Moat
7 days agoArgus Research